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A B S T R A C T
Background: To investigate potential facilitators and barriers for patients receiving specialised mental healthcare
using a longitudinal design.
Methods: Longitudinal data on 701 adult participants with a depressive and/or anxiety disorder were derived
from the Netherlands Study of Depression and Anxiety (NESDA). Demographic, clinical and treatment de-
terminants at baseline were assessed with self-report questionnaires and the Composite International Diagnostic
Interview (CIDI 2.1). Transition to specialised mental healthcare was assessed at one, two, four, and six-year
follow-up with a self-report resource use questionnaire (TiC-P).
Results: 28.3% of patients with a depressive and/or anxiety disorder transitioned from receiving no care or
primary mental healthcare to specialised mental health services during six-year follow-up. The multivariate Cox
regression model identified suicidal ideation, younger age, higher education level, openness to experience,
pharmacological treatment, prior treatment in primary mental healthcare and perceived unmet need for help as
determinants of transition, explaining 8–18% of variance.
Limitations: This study focused on baseline determinants of future transition to specialised mental healthcare.
Recovery and remittance of depression and anxiety in relation to transition were not studied.
Conclusions: Not all key clinical guideline characteristics such as severity of symptoms and comorbidity were
predictive of a transition to specialised mental healthcare, while non-clinical factors, such as age and perceived
unmet need for help, did influence the process.
1. Introduction
Major depressive disorder (MDD) and anxiety disorders are highly
prevalent and severely disabling, especially when persisting over time
(Demyttenaere et al., 2004; Kessler et al., 2015, 2005; Ten Have et al.,
2013a, 2013b). A substantial number of people with severe symptoms
of depression and/or anxiety do not receive adequate treatment
(Kohn et al., 2004), with estimates ranging between 30% and 50%
(Harvey and Gumport, 2015; Piek et al., 2011; Spijker et al., 2013;
Ten Have et al., 2013a, 2013b).
In the Netherlands, most people who suffer from depression and/or
anxiety initially go to their general practitioner (GP), who can provide
counselling or pharmacotherapy. This can be supplemented with short-
term out-patient psychotherapy (5–10 sessions) in primary care,
provided by social workers, social psychiatric nurses, public health
nurses or psychologists (Piek et al., 2011; Spijker et al., 2013; van
Balkom et al., 2013). In case of severe mental health problems, patients
can be referred to specialised mental healthcare. Compared to primary
care, specialised treatment is usually characterised by a more multi-
disciplinary approach and longer treatment duration. Treatment can
consist of individual sessions, group-therapy, day-treatment or in-pa-
tient care, and is most often provided by psychiatrists, psychotherapists
or psychologists.
According to formal clinical guidelines, referral to specialised
mental healthcare can be made by a GP, company doctor or medical
specialist. Criteria for referral are an inadequate treatment response to
the first steps of primary mental healthcare, comorbid disorders, com-
plex or severe symptoms such as suicidal behaviour, or chronic or
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recurring episodes (National Institute for Health and Care Excellence,
2011; Piek et al., 2011; Spijker et al., 2013; van Balkom et al., 2013;
van Hemert et al., 2012).
In order to better understand why some patients do not receive
adequate care, even though effective treatment is available, it is im-
portant to identify the barriers and facilitators for people receiving
mental healthcare. This provides healthcare professionals with valuable
information on which people are at risk of not getting the services they
require and ought to be followed up more thoroughly.
Previous cross-sectional research, examining the characteristics of
patients in specialised mental healthcare, showed that patients with
more severe or chronic symptoms were more likely to receive some
form of specialised mental healthcare (Harris et al., 2015; Piek et al.,
2011; ten Have et al., 2013a, 2013b; Verhaak et al., 2009; Wang et al.,
2007b, 2007a).
Other factors may also play an important role in the referral process.
For example, GP's confidence in their ability to detect mood and anxiety
disorders was shown to decrease the probability of referral to specia-
lised services, while perceiving more barriers for guideline im-
plementation increased the probability (Smolders et al., 2010). Con-
cerning patients’ demographic characteristics, several cross-sectional
studies found that females, highly educated individuals, people be-
tween 30 and 50 years old, and individuals without a paid job more
often receive specialised mental healthcare (Alonso et al., 2004; Bijl and
Ravelli, 2000; Harris et al., 2015; Kohn et al., 2004; ten Have et al.,
2013a, 2013b). Low perceived need for help was found to be an im-
portant reason for not receiving treatment, even when the financial
consequences of receiving care were minimal and when symptom se-
verity was high (Andrews et al., 2001).
Overall, it is still largely unclear to what extent formal clinical
Fig. 1. Flow-chart for the selection process of the study cohort.
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guidelines explain which patients receive specialised mental healthcare,
and which other, non-clinical, patient characteristics contribute to this
process. The current study expands on previous cross-sectional studies
by employing a longitudinal design. The central aim of this study is to
examine which depressed or anxious individuals transition to specia-
lised mental healthcare during a six-year timeframe. Various potential
determinants of transition are examined, including clinical character-
istics, demographic characteristics, prior treatment history and per-
ceived unmet need for help. Examining a broad range of determinants
provides the opportunity to establish whether guidelines are followed,
and to assess which other factors play a role in the processes of referral
and receiving help.
2. Material and methods
2.1. Study sample
Participant data were derived from the Netherlands Study of
Depression and Anxiety (NESDA), an on-going longitudinal cohort
study investigating the determinants, long-term course and con-
sequences of depressive and anxiety disorders (Penninx et al., 2008). At
baseline, the total NESDA sample consisted of 2981 adults (18–65 years
old) that were included between 2004 and 2007. Follow-up assessments
took place after one, two, four, and six years. A detailed overview of the
NESDA design and procedures can be found elsewhere (Penninx et al.,
2008).
NESDA included participants from different healthcare settings and
recruited people in various stages of depressive and/or anxiety dis-
orders. Participants were either healthy controls (26%) or fulfilled the
DSM-IV-TR criteria (American Psychiatric Association (APA), 2000) for
a current or remitted depressive disorder (Major Depressive Disorder or
Dysthymia) and/or an anxiety disorder (Social Phobia, Generalised
Anxiety Disorder, Agoraphobia, and Panic Disorder with or without
Agoraphobia) (74%).
Participants were recruited from the community (19%), primary
care (general practice, 54%) and specialised mental healthcare settings
(27%), thus representing different healthcare populations. Participants
with a primary diagnosis of other severe disorders, such as a psychotic,
obsessive-compulsive, bipolar, or severe addiction disorder were ex-
cluded from study participation. NESDA was approved by the Ethical
Review Board of the VU University Medical Centre and by the local
review boards of all participating centres. All participants provided
written informed consent. Fig. 1 illustrates the selection process of the
study cohort for the current study.
The study focused on participants who fulfilled the criteria for a
depressive disorder, an anxiety disorder or a comorbid depressive and
anxiety disorder in the six months prior to baseline assessment (DSM-
IV-TR) (American Psychiatric Association (APA), 2000) who were re-
cruited in the general population or in primary care (n=895). Diag-
noses were determined with the Lifetime Composite International Di-
agnostic Interview (CIDI) version 2.1 (World Health
Organisation (WHO), 1997). As the study aimed to assess long-term
determinants of participants transitioning to specialised mental
healthcare, participants who already received specialised mental
healthcare at baseline were excluded from the study sample. Data on
mental healthcare was available for the six months prior to baseline, via
the self-report Trimbos/iMTA questionnaire for costs associated with
psychiatric illness (TIC-P) (Hakkaart-van Roijen et al., 2002), matching
the six-month DSM diagnosis. Excluding participants that reported one
or more treatment contacts in specialised mental healthcare prior to
baseline led to a sample of n=759. Fifty-eight participants were ex-
cluded from data-analysis because of missing data on all follow-up as-
sessments, bringing the total study cohort to n=701.
2.2. Transition to specialised mental healthcare
The primary outcome variable transition to specialised mental
healthcare was defined as three or more visits within one follow-up
period to a specialised mental healthcare centre, an independent psy-
chiatrist or psychotherapist, and/or a centre specialised in treatment of
alcohol or drug abuse or dependence. In order to receive specialised
care, patients first require a formal referral by a GP, company doctor or
medical professional. Transition can take place either from primary
mental healthcare to specialised mental healthcare, or patients can
surpass primary care and transition directly to specialised care. The cut-
off of three visits was based on the assumption that in Dutch specialised
mental healthcare the first two sessions are generally focused on the
diagnostic phase, with specialised treatment starting from the third
session onwards. Information on use of mental healthcare was derived
from the TIC-P (Hakkaart-van Roijen et al., 2002), which assessed
(mental) healthcare contacts with various healthcare professionals
during each follow-up period. The TIC-P was administered one, two,
four, and six years after baseline. Time of event (transition to specia-
lised mental healthcare) was recorded as the first follow-up year at
which participants reported having had three or more specialised
mental healthcare contacts since their last assessment.
In order to gain insight into the amount of specialised mental
healthcare transitioned participants received during each follow-up
period, and the specific setting in which this took place, the number of
participants that visited each specialised mental healthcare setting was
examined, along with the mean number of contacts in each setting
during each follow-up period. At one-year follow-up, only information
on the combined number of visits to an independent psychiatrist and/or
psychotherapist was available. For two, four, and six-year follow-up,
information could be presented separately.
2.3. Determinants of time to transition to specialised mental healthcare
2.3.1. Demographic characteristics
The socio-demographic characteristics gender, age, years of education,
total household net income per month (below modal≤ €2400,- and
above modal> €2400,-) (Prins et al., 2011a, 2011b; van Beljouw et al.,
2010) and employment status (employed, unemployed) were assessed
during the baseline interview.
2.3.2. Clinical characteristics
At baseline, the CIDI interview (version 2.1) (World Health
Organisation (WHO), 1997) was used to assess whether participants
fulfilled the diagnosis of a depressive disorder (Major Depressive Disorder
or Dysthymia) and/or an anxiety disorder (Social Phobia, Generalised
Anxiety Disorder, Agoraphobia, and Panic Disorder with or without
Agoraphobia). In order to examine the predictive value of having a
depressive disorder, an anxiety diagnosis, or a combined diagnosis of
depression and anxiety, this information was coded into a three-level
categorical variable, with depression diagnosis as the reference cate-
gory. The CIDI diagnosis Alcohol Dependency was added as a separate
determinant to further assess the impact of comorbidity.
In order to gain insight into the predictive value of duration of
symptoms, both symptom duration and age of onset of the disorder were
assessed. Age of onset of depressive and anxiety disorders was de-
termined with the CIDI interview. When participants were diagnosed
with comorbid anxiety and/or depressive disorders, the age of onset of
the least recent disorder was used. Symptom duration was defined as
the percentage of time participants had symptoms of depression, an-
xiety or avoidance in the four to five years prior to baseline. This was
assessed with the Life Chart (Lyketsos et al., 1994) which was shown to
be an adequate instrument (Denicoff et al., 1997; Honig et al., 2001).
When participants reported experiencing symptoms in more than one
domain, the domain with the highest percentage was used.
Severity of depressive symptoms in the two weeks prior to baseline
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was assessed with the 30-item Inventory of Depressive Symptoms-Self
Report (IDS-SR30) (Rush et al., 1996, 1986). In order to assess anxiety
severity in the week prior to baseline, the 21-item Beck Anxiety In-
ventory (BAI) (Beck et al., 1988) was used. Within the NESDA sample,
Cronbach's alpha was 0.93 for both the IDS and BAI questionnaire.
Suicidal ideation the week prior to baseline was measured in a semi-
structured interview with the five-item Scale for Suicide Ideation
(Beck et al., 1979). Participants were considered to have a heightened
risk of suicide when they reported suicidal thoughts (a score of at least
two out of three) on at least one out of the five items.
The personality domains agreeableness, neuroticism, conscientious-
ness, extraversion and openness to experience were measured with the
60-item NEO personality questionnaire (Costa and McCrae, 1995).
Within the NESDA sample Cronbach's alpha ranged from 0.69 (open-
ness) to 0.90 (neuroticism).
2.3.3. Prior treatment
The predictive value of prior treatment received was evaluated by
assessing whether participants received primary mental healthcare
and/or pharmacotherapy prior to baseline. Treatment in primary
mental healthcare was measured with the TIC-P (Hakkaart-van Roijen
et al., 2002) and was defined as at least three mental healthcare con-
tacts in the six months prior to baseline with a GP, psychologist, social
worker, and/or social psychiatric nurse. Assessment of pharma-
cotherapy was based on medication packages of all psychoactive
medication participants used regularly for their depressive or anxious
symptoms in the month prior to baseline. The medication was then
rated by the interviewer, based on the World Health Organization
Anatomical Therapeutic Chemical (ATC) classification system
(World Health Organization Collaboration Centre for Drug Statistics
Methodology, 2016). It included antidepressants (tricyclic anti-
depressants (ATC code N06AA), selective serotonin reuptake inhibitors
(ATC code N06AB), other antidepressants (ATC codes N06AF, N06AG,
N06AX) and benzodiazepines (ATC codes N03AE, N05BA, N05CD,
N05CF).
2.3.4. Perceived need for help
Participants’ perceived unmet need for help in the six months prior
to baseline was assessed with the Perceived Need for Care questionnaire
(PNCQ), which was found to have an acceptable reliability and validity
for this type of study (Meadows et al., 2000). Participants specified
whether they received help in the domains of (1) psycho-education and
treatment information, (2) medicines and pills, (3) referral to a spe-
cialist, (4) psychotherapy and counselling, (5) practical support, and/or
(6) skills training during the six months prior to baseline and indicated
whether this matched their need. When participants reported that they
did not receive help in a domain despite having a need for help, they
were considered to have an unmet need for help in this domain. One
continuous variable was created, indicating the total amount of do-
mains in which participants had a perceived unmet need for help (range
0–6).
2.3.5. Statistical analyses
The probability of transitioning to specialised mental healthcare
during follow-up (one, two, four, and six years after baseline) was ex-
amined with the Kaplan-Meier estimate. Cox's proportional hazard
analyses were used to examine univariate and multivariate associations
between time to transition to specialised mental healthcare and possible
determinants. The following determinants were examined: (1) partici-
pants’ socio-demographic characteristics (age, gender, education level,
employment status and household income), (2) clinical factors (CIDI
anxiety, depression and/or alcohol dependence diagnoses, age of onset,
percentage of time during which participants had symptoms in past five
years, personality domains, number of chronic somatic diseases under
treatment, severity of depressive and anxiety symptoms and suicidal
ideation), and (3) participants’ mental healthcare prior to baseline
(psychotropic medication and/or primary mental healthcare contacts)
and perceived unmet need for help.
Subjects were right censored in the analysis at the last recorded
follow-up or when they did not transition to specialised mental
healthcare during the full six-year follow-up period. Time-point of
event (transition to specialised mental healthcare) was recorded as the
first follow-up at which the event occurred. Time was defined as 1, 2, 4
and 6, reflecting the follow-up time in years since baseline.
Proportional hazards were verified in order to rule out interactions
between time and the covariate levels. Predictor variables were ex-
amined for normality of sampling distribution, univariate outliers and
multivariate outliers. Multicollinearity between predictors was checked
by calculating the variance inflation factor (VIF; 1/(1-R2)) for each
determinant variable in the multivariate model. Values over 2.5 were
considered indicative of multicollinearity (Allison, 1999). The analysis
was run with the rms function (Harrell, 2018) in R software (R Core
Team, 2017).
Continuous variables were standardised, with a unit change re-
flecting a decrease or increase of one standard deviation. All Cox ana-
lyses were performed using the R survival package (Therneau, 2017).
Predictors that were significant at p= .20 (two-tailed) were included in
the multivariate model (Mickey and Greenland, 1989). In the multi-
variate model a significance level of p< .05 (two-tailed) was applied.
In order to examine the combined impact of all significant patient
characteristics, a cumulative score was calculated from all determinants
that were significantly related to transition to specialised mental
healthcare. A logistic regression model was performed with transition




Mean age of the total study sample was 44.4 years (SD 12.7, range
18–65). The sample consisted of more women than men (n=506,
72.2%). At baseline, most participants were diagnosed with an anxiety
disorder in the past six months (n=311, 44.4%), 229 participants were
diagnosed with both an anxiety and a depressive disorder (32.7%), and
the remaining 161 participants (23.0%) were diagnosed with a de-
pressive disorder. Table 1 provides an overview of differences in
baseline demographic and clinical characteristics between participants
who transitioned to specialised mental healthcare and participants who
did not.
3.2. Transition to specialised mental healthcare
Over the course of six years, 198 out of 701 participants (28.3%)
transitioned to specialised mental healthcare, reporting at least three
contacts in a specialised mental healthcare setting. The slope of the
survival curve suggests that most participants who transitioned to
specialised mental healthcare did so during the first year after baseline
(n=66, 33.3%) or in the second year (n=58, 29.3%). After four years,
an additional 35 (17.7%) participants reported a transition to specia-
lised mental healthcare, followed by 39 (19.7%) participants at six-year
follow-up. Table 2 provides an overview per follow-up assessment of
the number of transitioned participants that reported receiving treat-
ment at each specialised mental healthcare provider (independent
psychiatrist or psychotherapist, specialised centre and/or at a centre
specialised in treatment of alcohol or drug abuse or dependence) and
the mean number of contacts per follow-up.
3.3. Determinants
Univariate Cox regression analyses were used to assess predictive
value for time to transition to specialised mental healthcare for (1) the
L.C. Kooistra et al. Journal of Affective Disorders 241 (2018) 226–234
229
demographic characteristics age, gender, relationship status, years of
education, employment status and income, (2) the clinical baseline char-
acteristics depressive and/or anxiety disorder, age of onset of current di-
agnosis, symptom duration, comorbid alcohol dependence, depression and
anxiety severity, suicidal ideation, the NEO personality domains and the
number of chronic somatic diseases under treatment, (3) prior pharmaco-
logical treatment and primary care, and perceived unmet need for help.
Outcomes of univariate analyses can be found in Table 3.
Based on an alpha of 0.20, the baseline determinants age, years of
education, relationship status, age of onset, income level, alcohol depen-
dence, depression severity, anxiety severity, suicidal ideation, neuroticism,
extraversion, openness to experience, conscientiousness, pharmacological
treatment, prior treatment in primary care, and unmet need for help were
included in the multivariate model (see Table 3).
Before running the multivariate model, multicollinearity between
predictors was checked by calculating the variance inflation factor
(VIF) for each determinant variable in the multivariate model. For de-
pression severity a VIF score was found of 2.71, other determinants had
a VIF score below cut-off (VIF<2.5). Based on this finding, the mul-
tivariate model was performed both with and without depression se-
verity as a determinant. Removing depression severity from the mul-
tivariate model did not impact the other outcomes. Therefore,
depression severity was kept as a determinant in the multivariate
model.
In the multivariate model, age, years of education, suicidal ideation,
openness to experience, pharmacological treatment, prior treatment in pri-
mary mental healthcare, and perceived unmet need for help significantly
predicted time to transition.
Participants who reported suicidal ideation, had a 1.9 times higher
probability of transitioning than participants who did not have suicidal
ideation (β=0.657, HR=1.93 95% CI: 1.34 to 2.78, p< .001).
Participants who reported more openness to experience, had a relative
probability of 18% per standard deviation (SD=5.3, β=0.162,
HR=1.18 95% CI: 1.00 to 1.38, p= .05). Participants who received
pharmacological treatment at baseline had 1.45 higher probability of
transitioning to specialised care (β=0.370, HR=1.45 95% CI: 1.03 to
2.03, p= .033). Participants who received three or more mental
healthcare contacts in primary care in the six months prior to baseline,
had 1.55 higher probability of transitioning to specialised care
(β=0.437, HR=1.55 95% CI: 1.13 to 2.12, p= .006). Participants
who had an unmet need for help, had a relative probability of 19% per
standard deviation (SD=0.87, β=0.173, HR=1.19, 95% CI: 1.06 to
1.34, p= .004). With each standard deviation increase in age the
probability of transitioning decreased with 17% (SD=12.7,
β=−0.189, HR=0.83, 95% CI: 0.70 to 0.98, p= .030). Participants
who reported more years of education had a significantly increased
probability of transitioning of 27% per standard deviation (SD=3.3,
β=0.242, HR=1.27, 95% CI: 1.09 to 1.49, p= .003). The predictive
value of the set of determinants was R2=0.14 (estimated 95% CI: 0.08
to 0.18, using R-square software (R Core team, 2017)).
Table 4 presents the odds of transitioning to specialised mental
healthcare for subject groups with various risk profiles. In order to
calculate the cumulative score, continuous variables were dichotomised
based on median split: age (≥ 48 years old), years of education (≥ 11),
openness of experience (≥ 26). For perceived unmet need for help, a
cut-off of one domain or more was used.
Because only 39 participants did not have any significant determi-
nants in their profile, participants with zero to one determinants were
grouped together, and used as a reference group (n=144). Compared
to the reference group, the odds of transition did not significantly in-
crease when participants had two determinants in their profile
Table 1
Baseline characteristics of the study sample.
Baseline characteristics





Age (mean ± SD) 45.3 (12.8) 42.1 (12.3) 44.4 (12.7)
Gender: Females (n, %) 367 (73.0) 139 (70.2) 506 (72.2)
In a relationship (yes, n, %) 352 (70.0) 125 (63.1) 477 (68.0)
Years of education (mean ± SD) 11.4 (3.2) 12.6 (3.5) 11.7 (3.3)
Employed (n, %) 424 (84.3) 163 (82.3) 587 (83.7)
Household income per month (n,
%)
Below modal (≤ €2400,-) 316 (45.1) 187 (26.7) 450 (64.2)
Above modal (> €2400,-) 134 (19.1) 64 (9.1) 251 (35.8)
Clinical characteristics
Six-month diagnosis (n, %)
Depression 111 (22.1) 50 (25.3) 161 (23.0)
Anxiety 232 (46.1) 79 (39.9) 311 (44.4)
Comorbid Depression/Anxiety 160 (31.8) 69 (34.8) 229 (32.7)
Age of onset (mean ± SD) 22.9 (13.6) 19.2 (11.4) 21.9 (13.1)
Symptom duration (mean ± SD) 45.0 (35.3) 46.6 (33.5) 45.5 (34.8)
Diagnosis alcohol abuse/
dependence (n, %)
146 (29.0) 78 (39.4) 224 (32.0)
Depression severity
(mean ± SD)
24.5 (10.9) 28.6 (10.7) 25.7 (11.0)
Anxiety severity (mean ± SD) 14.2 (9.1) 16.1 (9.7) 14.7 (9.3)
Suicidal ideation in past week (n,
%)
47 (9.3) 50 (25.3) 97 (13.8)
Personality characteristics
(mean ± SD)
Neuroticism 39.2 (7.3) 41.1 (6.5) 39.7 (7.1)
Extraversion 35.6 (6.7) 34.5 (6.5) 35.3 (6.6)
Agreeableness 43.1 (5.2) 42.9 (5.2) 43.0 (5.2)
Openness 30.7 (5.3) 32.5 (5.2) 31.2 (5.4)
Conscientiousness 37.1 (5.7) 35.9 (6.4) 36.8 (5.9)
# of somatic diseases
(mean ± SD)
No somatic disease 246 (48.9) 96 (48.5) 342 (48.8)
One somatic disease 167 (33.2) 67 (33.8) 234 (33.4)
Two or more somatic diseases 90 (17.9) 35 (17.7) 125 (17.8)
Psychotropic medication (n, %) 118 (23.5) 57 (28.8) 175 (25.0)
Primary mental healthcare (n, %)
Three or more contacts 144 (28.6) 90 (45.5) 234 (33.4)
Unmet need for help
(mean ± SD)
0.30 (0.78) 0.65 (1.00) 0.40 (0.87)
Note. SD: Standard Deviation; SMHC: Specialised Mental Healthcare.
Table 2
Overview of specialised mental healthcare received by transitioned participants: mean number of visits per follow-up.
Specialised centre Psychiatrist2 Psychotherapist2 Centre for alcohol/drugs
Year N1 n Contacts n Contacts n Contacts n Contacts
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
One 66 24 13.7 (22.1) 39 11.3 (5.5) – – 3 8.0 (4.9)
Two 58 36 20.2 (23.8) 7 12.4 (8.5) 13 13.4 (12.1) 2 11.5 (5.0)
Four 35 17 35.2 (34.9) 7 15.4 (18.4) 12 12.1 (9.3) 3 33.7 (29.7)
Six 39 23 16.9 (26.3) 7 17.4 (25.6) 11 23.0 (30.1) 2 16.0 (5.7)
Note. 1: Number of transitioned participants per follow-up. 2: Independent professional (not employed by a specialised mental healthcare centre). At one-year follow-
up only information on the combined number of visits to an independent psychiatrist and/or psychotherapist was available.
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(n= 204, OR=1.61, 95% CI: 0.92–2.89, p= .102). The odds did in-
crease significantly when participants had three (n= 187, OR=2.44,
95% CI: 1.44–4.35, p= .002), or four or more determinants
(OR=5.25, 95% CI: 3.06–9.32, p< .001). This finding suggests there
is a cumulative effect of the number of determinants present in patients’
profiles, increasing the probability that participants transitioned to
specialised mental healthcare.
4. Discussion
This longitudinal study examined possible determinants of partici-
pants with a current DSM-IV diagnosis of depression and/or anxiety
transitioning to specialised mental healthcare over the course of six
years. Out of 701 participants, 198 (28.3%) transitioned to specialised
mental healthcare. Transition most often took place within two years
after baseline (n=124, 63%). In a multivariate model, younger age,
years of education, suicidal ideation, openness to experience, prior
pharmacological treatment and primary mental healthcare, and a per-
ceived unmet need for help, significantly predicted time to transition.
When participants' profiles included three or more determinants, the
probability of transitioning to specialised care increased significantly.
4.1. Clinical profile and need for help
Participants who already received pharmacotherapy or primary
mental healthcare at baseline, had an increased probability of transi-
tioning to specialised services compared to participants who were not
yet receiving one of these types of care. This finding seems to be in line
with treatment and referral guidelines, which focus on a stepped-care
approach and encourage healthcare professionals to refer patients who
still experience symptoms after the first steps of mental healthcare
(National Institute for Health and Care Excellence, 2011; Piek et al.,
2011; Spijker et al., 2013; van Balkom et al., 2013). However, this
explanation might be less relevant for participants who did not transi-
tion until four to six years after the baseline measurement. In addition,
prior treatment could have been aimed at a diagnosis or problem other
than depression or anxiety.
When participants reported that they did not receive help despite
having a need for help (perceived unmet need for help), they had an
increased probability of transitioning to specialised care. This is in line
with prior research (Andrews et al., 2001). Possibly, participants who
Table 3
Hazard ratio's: relative probability for transition to specialised mental healthcare.
Univariate analyses Multivariate analyses (n=689)
N HR 95% CI p-value HR 95% CI p-value
Demographics
Age (mean ± SD)* 701 0.792 0.69; 0.91 .001 0.827 0.70; 0.98 .030
Gender: Females (n, %) 701 0.921 0.68; 1.25 .599
In a relationship (yes, n, %) 701 0.783 0.59; 1.05 .097 0.903 0.65; 1.25 .538
Years of education (mean ± SD)* 701 1.319 1.15; 1.51 <.001 1.270 1.09; 1.49 .003
Employed (n, %) 701 0.886 0.62; 1.28 .514
Household income per month (n, %) 701
Below modal (≤ €2400,-) Ref.
Above Modal (> €2400,-) 0.819 0.61; 1.10 .185 0.857 0.72; 1.03 .379
Clinical characteristics
Six-month diagnosis (n, %) 701
Depression Ref.
Anxiety 0.808 0.57; 1.15 .238
Comorbid Depression/Anxiety 1.004 0.70; 1.45 .982
Age of onset (mean ± SD)* 697 0.777 0.67; 0.90 .001 0.863 0.61; 1.21 .099
Symptom duration (mean ± SD)* 694 1.030 0.90; 1.18 .668
Diagnosis alcohol abuse/dependence (n, %) 701 1.460 1.10; 1.94 .009 1.185 0.88; 1.60 .266
Depression severity (mean ± SD)* 696 1.530 1.29; 1.82 <.001 1.329 0.99; 1.78 .055
Anxiety severity (mean ± SD)* 697 1.247 1.07; 1.45 .004 0.913 0.73; 1.15 .435
Suicidal ideation in past week (n, %) 701 2.616 1.90; 3.61 <.001 1.929 1.34; 2.78 <.001
Personality characteristics (mean ± SD)*
Neuroticism 696 1.401 1.16; 1.70 <.001 0.971 0.74; 1.27 .830
Extraversion 696 0.854 0.73; 1.00 .048 0.985 1.00; 1.38 .883
Agreeableness 696 0.941 0.82; 1.09 .409
Openness 696 1.305 1.14; 1.50 <.001 1.178 0.80; 1.21 .046
Conscientiousness 696 0.819 0.71; 0.95 .007 0.953 0.81; 1.13 .569
# of somatic diseases (mean ± SD) 701
No somatic disease Ref
One somatic disease 1.024 0.75; 1.40 .880
Two or more somatic diseases 1.004 0.68; 1.48 .983
Psychotropic medication (n, %) 701 1.239 0.91; 1.69 .172 1.447 1.03; 2.03 .033
Primary mental healthcare (n, %)
Three or more contacts 701 1.902 1.44; 2.52 <.001 1.548 1.13; 2.12 .006
Unmet need for help (mean ± SD)* 701 1.295 1.18; 1.43 <.001 1.189 1.06; 1.34 .004
Note. * Standardised for Cox regression analyses; SD: Standard Deviation; SMHC: Specialised Mental Healthcare. In bold: p-value significant (univariate: a>0.20,
multivariate: a>0.05).
Table 4
Number of determinants present in participants per group and odds of transi-











n (%) n (%) n (%)
0–1 123 (24.5) 21 (10.6) 144 (20.6) Ref
2 160 (31.8) 44 (22.2) 204 (29.1) 1.61 (0.92;
2.89)
3 132 (26.2) 55 (27.8) 187 (26.7) 2.44 (1.41;
4.35)**
4+ 88 (17.5) 78 (39.4) 166 (23.7) 5.25 (3.06;
9.32)***
Note. SMHC: specialised mental healthcare. ** p< .01; *** p< .001.
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were aware of their need for help were more inclined to start specia-
lised treatment than participants who were not. Another explanation is
that healthcare professionals take their patients’ needs into account
when determining mental healthcare trajectories. However, whether
this was actually the case could not be examined in the current study.
In the current study, comorbid disorders, symptom duration and
self-reported symptom severity lost their univariate predictive value
within the multivariate model. This was unexpected, as these variables
are also important referral criteria and prior cross-sectional research
did suggest that individuals with more severe symptoms are more likely
to receive mental healthcare (Ten Have et al., 2013a, 2013b; Verhaak
et al., 2009; Wang et al., 2007a, 2007b). Part of this finding can be
explained by the predictive value of suicidal ideation, as this is also a
severity marker. In the NESDA sample for example, suicidal partici-
pants were shown to be more severely ill than participants with de-
pression or anxiety who did not display suicidal ideation (Stringer et al.,
2013). However, suicidal ideation was reported by a quarter of tran-
sitioned participants, indicating that three quarters of participants
transitioned to specialised mental healthcare based on other criteria.
4.2. Demographic characteristics
The predictive value of age matched earlier studies (Alonso et al.,
2004; Kohn et al., 2004), suggesting that persons who are older have a
lower probability of transitioning to specialised mental healthcare than
younger persons with a similar clinical profile. Even though age is not
included in formal guidelines, it appears to be worthwhile for GPs to
more closely monitor this older patient group.
In the current study, years of education also predicted transition to
specialised mental healthcare independently of clinical severity char-
acteristics, while controlling for other demographic variables such as
employment and household income. More highly educated participants
had a higher probability of transitioning to specialised services.
Possibly, more highly educated individuals are better at voicing their
needs and explaining their symptoms, thereby increasing their prob-
ability of referral.
4.3. Strengths and limitations
This study was, to our knowledge, one of the first to employ a
longitudinal epidemiological design in order to assess the long-term
mental healthcare trajectories of people with an anxiety and/or de-
pressive disorder. Examining a broad range of determinants provides
opportunity to examine which factors play a role in the process of re-
ferral and help seeking.
The current set of determinants does pose some methodological
challenges, such as the determinant to event ratio, multiple testing and
(multi)collinearity between determinants. To examine the precise in-
dividual contribution of determinants to the joint prediction, a larger
sample would be required. As the number of events to determinant ratio
decreases, the estimations become more biased. However, the de-
terminant to event ratio (1:9) was close to the threshold of 1:10 that
was suggested by Peduzzi and colleagues for proportional Hazard re-
gression analyses (Peduzzi et al., 1995). Further, while collinearity was
present, for all but one determinant (depression severity) the values
were within the acceptable margin. Removing depression severity as a
determinant from the multivariate model did not affect outcomes.
There are also some considerations, regarding sample selection and
outcome measures, to be taken into account when interpreting the data.
Future studies are advised to examine the extent to which participants
experience stigma, because this could also have a major impact on
mental health, identification of mental disorders and healthcare tra-
jectories (Prins et al., 2011a, 2011b; Whiteford et al., 2013).
Participants and their mental healthcare professionals were not
necessarily aware or in agreement that a mental disorder was present.
This likely will have impacted transition to specialised care. In the
current study this information could not be taken into account, because
it was not available for all participants. A previous NESDA study ex-
amining patient records in the primary care sample, showed that GP's
correctly recognised 69% of the depressed participants and 81% of non-
depressed participants (Joling et al., 2011). This suggests that while
identification rates by GP's were high, a substantial number of patients
might have been under-diagnosed or over-diagnosed.
Participants were included when they did not receive specialised
mental healthcare in the six-months prior to baseline, matching a six-
month DSM diagnosis. No criterion could be added for specialised
treatment before this time-period. Consequently, it is possible that, for a
subgroup of participants, a return to specialised services was measured,
rather than a first transition. Possibly, clinical profiles in this group
differed from those of participants who did not receive specialised
treatment before, for example in terms of symptom severity or duration.
It would be interesting for future studies to examine the full mental
healthcare trajectories over time, rather than to focus on one transition.
Combined with specific information on type of treatment received,
treatment response and remission rates, this could add to the knowl-
edge on treatment availability and effectiveness. Also, an interesting
next step in future research would be to examine the reasons for referral
and transition to specialised mental healthcare according to both pa-
tients and healthcare professionals. In this context, a mixed-method
approach could be considered. This could shed more light on barriers
and facilitators for receiving mental healthcare.
5. Conclusions
Combining all information, the current study suggests that transi-
tion to specialised mental healthcare could only be partly explained by
clinical characteristics that are included in official clinical referral
guidelines.
The clinical characteristics suicidal ideation and prior treatment
proved to be important determinants. However, other clinical factors
such as comorbidity, symptom duration and symptom severity did not
contribute to the probability of transition to specialised mental
healthcare. Age, education level, openness to experience and perceived
unmet need for help were related to transition to specialised services,
even though these factors are not included in guidelines. Participants
with combined profiles including three or more determinants, were
shown to have an increased probability of transitioning to specialised
mental healthcare. Groups that might be at risk of under-treatment
according to the findings in this study are older adults and people with
lower education. It would therefore be advisable for mental healthcare
professionals to pay specific attention to these patients, making sure
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